Losartan Potassium Tablet, Film Coated
Product Images NDC 42708-125

Product Visual Gallery

This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Losartan Potassium (NDC 42708-125). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Qpharma, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Label (42708 125 30)

This is a package instruction for the medication Losartan Potassium. It suggests a controlled dosage (not specified) and advises to consult the package insert for dosage information. The medication should be stored at room temperature. The remaining text is not readable ( error).*

FDA Label Image

Figure1 (Losartan Fig1)

The text mentions two drugs: Atenolol and Losartan Potassium. There is also a statistic of "Adjusted Risk Reduction: 13%" with a value of "p=" that is not complete. It also mentions different study months. However, without further context or information, it is not possible to provide a specific description or explanation.*

FDA Label Image

Figure2 (Losartan Fig2)

FDA Label Image

Figure 3 (Losartan Fig3)

FDA Label Image

Figure-4 (Losartan Fig4)

This text represents the results of a study or trial comparing the effects of Losttan Potassium versus a placebo. The percentage of patients who experienced an event was 60% in the Losttan group, and 40% in the placebo group. The risk reduction was calculated to be 16.1%. The p-value was 0.022. Unfortunately, there is no context regarding the type of event or condition being studied.*

FDA Label Image

Chemical Structure (Losartan Str)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.